The investigators are planning to find the right modification of traditionally used risk scores (PASI, DLQI) in patients with psoriasis of different severity to guide the treatment that could potentially extend life, improve cardiovascular outcomes and quality of life in patients with psoriasis and cardiovascular risk factors in a prospective observational study. The traditionally excluded groups of older patients with diabetes mellitus, decreased kidney function and those with potentially worse prognosis are going to be included in the study. As it's known, the number of those patients is on the rise each year and require a close attention of multidisciplinary teams.
Study Type
OBSERVATIONAL
Enrollment
200
University Clinical Hospital #2
Moscow, Russia
SCORE2-OP risk (Systematic COronary Risk Evaluation2- Older Person)
Increased cardiovascular risk over the follow-up period (from low to very high)
Time frame: 1 year
Overall mortality
Number of deaths due to all reasons
Time frame: 1 year
Cardiovascular mortality
Number of deaths due to cardiovascular reasons
Time frame: 1 year
Progression of psoriasis (PASI)
Progression of severity of psoriasis according to PASI (The Psoriasis Area and Severity Index - 0 to 4, none to very severe) score
Time frame: 1 year
Quality of life (DLQI score)
Impact on quality of life by DLQI (Dermatology Life Quality Index - 0 to 30, no to extremely large impact) score
Time frame: 1 year
Hospitalization due to cardiovascular reasons
Number of patients hospitalized due to cardiovascular reasons
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.